Weighting composite endpoints in clinical trials: Essential evidence for the heart team

Annals of Thoracic Surgery

Volumn 94, Issue 6, 2012, Pages 1908-1913

  Tong, Betty C ^a   Huber, Joel C ^b   Ascheim, Deborah D ^c   Puskas, John D ^d   Ferguson, T Bruce ^e   Blackstone, Eugene H ^f   Smith, Peter K ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e EAST CAROLINA UNIVERSITY   (United States)

^f LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL (TOPIC); CONVALESCENCE; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY BYPASS SURGERY; CORONARY STENT; FEMALE; HEALTH SURVEY; HEART INFARCTION; HUMAN; LONGEVITY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REPEAT PROCEDURE; REVASCULARIZATION; RISK ASSESSMENT;

EID: 84870022282     PISSN: 00034975     EISSN: 15526259     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2012.05.027     Document Type: Article

References (24)

1. N. Freemantle, M. Calvert, J. Wood, J. Eastaugh, C. Griffin Composite outcomes in randomized trials: greater precision but with greater uncertainty? JAMA 289 2003 2554 2559
2. KnowledgePanel, 1998-2011 http://www.knowledgenetworks.com/knpanel/index. html Accessed August 15, 2011
3. A.P. Kappetein, T.E. Feldman, M.J. Mack Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial Eur Heart J 32 2011 2125 2134
4. Sawtooth Software Technical Papers Library, 2012 http://www. sawtoothsoftware.com/education/techpap.shtml Accessed March 28, 2012
5. C.J. DeFrances, C.A. Lucas, V.C. Buie, A. Golosinskiy 2006 National Hospital Discharge Survey Natl Health Stat Rep 5 2008 1 20
6. P.W. Serruys, Y. Onuma, S. Garg Five year clinical outcomes of the ARTS II (Arterial Revascularization Therapies Study II) of the sirolimus-eluting stent in the treatment of patients with multivessel de novo coronary artery lesions J Am Coll Cardiol 55 2010 1093 1101
7. A.J. Epstein, D. Polsky, F. Yang, L. Yang, P.W. Groeneveld Coronary revascularization trends in the United States, 2001-2008 JAMA 305 2011 1769 1776
8. E.L. Hannan, M.J. Racz, J. Gold Adherence of catheterization laboratory cardiologists to American College of Cardiology/American Heart Association guidelines for percutaneous coronary interventions and coronary artery bypass graft surgery: what happens in actual practice? Circulation 121 2010 267 275
9. G.S. Chung, R.E. Lawrence, F.A. Curlin, V. Arora, D.O. Meltzer Predictors of hospitalised patients' preferences for physician-directed medical decision-making J Med Ethics 38 2012 77 82
10. S.S. Bederman, N.N. Mahomed, H.J. Kreder, W.J. McIsaac, P.C. Coyte, J.G. Wright In the eye of the beholder: preferences of patients, family physicians, and surgeons for lumbar spinal surgery Spine 35 2010 108 115
11. L.J. Caldon, S.J. Walters, J. Ratcliffe, M.W. Reed What influences clinicians' operative preferences for women with breast cancer? An application of the discrete choice experiment Eur J Cancer 43 2007 1662 1669
12. S.G. Thrumurthy, J.J. Morris, M.M. Mughal, J.B. Ward Discrete-choice preference comparison between patients and doctors for the surgical management of oesophagogastric cancer Br J Surg 98 2011 1124 1131
13. D.A. Marshall, F.R. Johnson, N.A. Kulin How do physician assessments of patient preferences for colorectal cancer screening tests differ from actual preferences? A comparison in Canada and the United States using a stated-choice survey Health Econ 18 2009 1420 1439
14. L. Mauri, P. Garg, J.M. Massaro The EVEREST II trial: design and rationale for a randomized study of the Evalve MitraClip system compared with mitral valve surgery for mitral regurgitation Am Heart J 160 2010 23 29
15. P.W. Serruys, M.C. Morice, A.P. Kappetein Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease N Engl J Med 360 2009 961 972
16. R.B. D'Agostino, J.M. Massaro, L.M. Sullivan Non-inferiority trials: design concepts and issues The encounters of academic consultants in statistics Stat Med 22 2003 169 186
17. S. Kaul, G.A. Diamond Making sense of noninferiority: a clinical and statistical perspective on its application to cardiovascular clinical trials Prog Cardiovasc Dis 49 2007 284 299
18. T.H. Lee, L.D. Hillis, E.G. Nabel CABG vs. stenting - clinical implications of the SYNTAX trial N Engl J Med 360 2009 e10
19. M. Krahn, G. Naglie The next step in guideline development: incorporating patient preferences JAMA 300 2008 436 438
20. L.D. Hillis, P.K. Smith, J.L. Anderson 2011 ACCF/AHA guideline for coronary artery bypass graft surgery: executive summary J Am Coll Cardiol 58 2011 e123 e210
21. D.J. Cohen, T.A. Lavelle, B. Van Hout Economic outcomes of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with left main or three-vessel coronary artery disease: One-year results from the SYNTAX trial Catheter Cardiovasc Interv 79 2012 198 209
22. J.R. Pleis, B.W. Ward, J.W. Lucas Summary health statistics for U.S. adults: National Health Interview Surgery, 2009 Vital Health Stat 2010 10
23. V. Regitz-Zagrosek, E. Lehmkuhl, B. Hocher Gender as a risk factor in young, not in old, women undergoing coronary artery bypass grafting J Am Coll Cardiol 44 2004 2413 2414
24. K.R. Humes, N.A. Jones, R.R. Ramirez Overview of race and Hispanic origin: 2010 Census brief 2011 US Census Bureau Washington, DC 4